Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Vaccines

  Free Subscription


Articles published in Virus Res

Retrieve available abstracts of 22 articles:
HTML format
Text format



Single Articles


    May 2018
  1. SHOKOUHI H, Farahmand B, Ghaemi A, Mazaheri V, et al
    Vaccination with three tandem repeats of M2 extracellular domain fused to Leismania major HSP70 protects mice against influenza A virus challenge.
    Virus Res. 2018;251:40-46.
    PubMed     Text format     Abstract available


    January 2018
  2. BHATT M, Mohapatra JK, Pandey LK, Mohanty NN, et al
    Mutational analysis of foot and mouth disease virus nonstructural polyprotein 3AB-coding region to design a negative marker virus.
    Virus Res. 2018;243:36-43.
    PubMed     Text format     Abstract available


    December 2017
  3. KIM SC, Won YH, Park JS, Jeon JS, et al
    Vaccine-Type Mutations Identified in Varicella Zoster Virus Passaged in Cell Culture.
    Virus Res. 2017 Dec 11. pii: S0168-1702(17)30833.
    PubMed     Text format     Abstract available


    September 2017
  4. WANG Y, Zhang Y, Wu J, Lin Y, et al
    Recombinant influenza H7 hemagglutinin containing CFLLC minidomain in the transmembrane domain showed enhanced cross-protection in mice.
    Virus Res. 2017;242:16-23.
    PubMed     Text format     Abstract available


    June 2017
  5. ZHANG X, Qin C, Li W, Zheng Z, et al
    Isolation and Characterization of a Highly Evolved Type 3 Vaccine-Derived Poliovirus in China.
    Virus Res. 2017 Jun 29. pii: S0168-1702(17)30314.
    PubMed     Text format     Abstract available


    May 2017
  6. LI Y, Yan S, Li X, Yang Q, et al
    From mouse to pig: is PRV vaccine safe across two species?
    Virus Res. 2017 May 5. pii: S0168-1702(17)30197.
    PubMed     Text format     Abstract available


    April 2017
  7. MUNOZ-ALIA MA, Casasnovas JM, Celma ML, Carabana J, et al
    Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies.
    Virus Res. 2017 Apr 29. pii: S0168-1702(17)30127.
    PubMed     Text format     Abstract available


  8. FULTON RW, Neill JD, Saliki JT, Landis C, et al
    Genomic and antigenic characterization of bovine parainfluenza-3 viruses in the United States including modified live virus vaccine (MLV) strains and field strains from cattle.
    Virus Res. 2017 Apr 14. pii: S0168-1702(17)30110.
    PubMed     Text format     Abstract available


    March 2017
  9. MA Y, Lu Y, Guan G, Luo J, et al
    Flower-like ZnO nanostructure assisted loop-mediated isothermal amplification assay for detection of Japanese encephalitis virus.
    Virus Res. 2017;232:34-40.
    PubMed     Text format     Abstract available


  10. CHRISTENSEN ND, Budgeon LR, Cladel NM, Hu J, et al
    Recent advances in preclinical model systems for papillomaviruses.
    Virus Res. 2017;231:108-118.
    PubMed     Text format     Abstract available


    February 2017
  11. MANJUNATH S, Mishra BP, Mishra B, Sahoo AP, et al
    Comparative and temporal transcriptome analysis of peste des petits ruminants virus infected goat peripheral blood mononuclear cells.
    Virus Res. 2017;229:28-40.
    PubMed     Text format     Abstract available


  12. CZARNECKI MW, Traktman P
    The vaccinia virus DNA polymerase and its processivity factor.
    Virus Res. 2017 Feb 1. pii: S0168-1702(16)30833.
    PubMed     Text format     Abstract available


    January 2017
  13. STACHYRA A, Pietrzak M, Maciola A, Protasiuk A, et al
    A prime/boost vaccination with HA DNA and Pichia-produced HA protein elicits a strong humoral response in chickens against H5N1.
    Virus Res. 2017;232:41-47.
    PubMed     Text format     Abstract available


    December 2016
  14. YANG A, Farmer E, Lin J, Wu TC, et al
    The current state of therapeutic and T cell-based vaccines against human papillomaviruses.
    Virus Res. 2016 Dec 5. pii: S0168-1702(16)30556.
    PubMed     Text format     Abstract available


    November 2016
  15. SCHELLENBACHER C, Roden RB, Kirnbauer R
    Developments in L2-based Human Papillomavirus (HPV) Vaccines.
    Virus Res. 2016 Nov 23. pii: S0168-1702(16)30528.
    PubMed     Text format     Abstract available


    September 2016
  16. ILLIANO E, Bissa M, Paolini F, Zanotto C, et al
    Prime-boost therapeutic vaccination in mice with DNA/DNA or DNA/Fowlpox virus recombinants expressing the Human Papilloma Virus type 16 E6 and E7 mutated proteins fused to the coat protein of Potato virus X.
    Virus Res. 2016;225:82-90.
    PubMed     Text format     Abstract available


    August 2016
  17. CRAWFORD K, Lager KM, Kulshreshtha V, Miller LC, et al
    Status of vaccines for porcine epidemic diarrhea virus in the United States and Canada.
    Virus Res. 2016 Aug 18. pii: S0168-1702(16)30366.
    PubMed     Text format     Abstract available


  18. KIM BC, Kim DK, Kim HJ, Hong SH, et al
    A collaborative study of an alternative in vitro potency assay for the Japanese encephalitis vaccine.
    Virus Res. 2016;223:190-196.
    PubMed     Text format     Abstract available


    July 2016
  19. ZUNIGA S, Pascual-Iglesias A, Sanchez CM, Sola I, et al
    VIRULENCE FACTORS IN PORCINE CORONAVIRUSES AND VACCINE DESIGN.
    Virus Res. 2016 Jul 7. pii: S0168-1702(16)30399.
    PubMed     Text format     Abstract available


    June 2016
  20. FULTON RW, d'Offay JM, Dubovi EJ, Eberle R, et al
    Bovine Herpesvirus-1: Genetic Diversity of Field Strains from Cattle with Respiratory Disease, Genital, Fetal Disease and Systemic Neonatal Disease and Their Relationship to Vaccine Strains.
    Virus Res. 2016 Jun 29. pii: S0168-1702(16)30231.
    PubMed     Text format     Abstract available


    May 2016
  21. LANGEL SN, Paim FC, Lager KM, Vlasova AN, et al
    Lactogenic Immunity and Vaccines for Porcine Epidemic Diarrhea Virus (PEDV): Historical And Current Concepts.
    Virus Res. 2016 May 19. pii: S0168-1702(16)30215.
    PubMed     Text format     Abstract available


  22. TERASAKI K, Tercero BR, Makino S
    Single-cycle replicable Rift Valley fever virus mutants as safe vaccine candidates.
    Virus Res. 2016;216:55-65.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: